These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 19702853)

  • 1. Clinical significance of IgG antibody titer against Helicobacter pylori.
    Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
    Helicobacter; 2009 Jun; 14(3):231-6. PubMed ID: 19702853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen.
    Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
    Acta Oncol; 2008; 47(3):360-5. PubMed ID: 18347999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between polymorphisms in glutathione S-transferase Mu3 and IgG titer levels in serum against Helicobacter pylori.
    Tatemichi M; Iwasaki M; Sasazuki S; Tsugane S
    J Hum Genet; 2009 Oct; 54(10):557-63. PubMed ID: 19696791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study.
    Kato S; Onda M; Matsukura N; Tokunaga A; Matsuda N; Yamashita K; Shields PG
    Cancer; 1996 Apr; 77(8 Suppl):1654-61. PubMed ID: 8608558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori.
    Suzuki G; Cullings H; Fujiwara S; Hattori N; Matsuura S; Hakoda M; Akahoshi M; Kodama K; Tahara E
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1224-8. PubMed ID: 17548689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
    Sun LP; Gong YH; Wang L; Gong W; Yuan Y
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2826-30. PubMed ID: 17200016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Helicobacter pylori infection and gastric cardia cancer: a nested case-control study].
    Ren JS; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):428-31. PubMed ID: 19024516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer.
    Adamsson J; Lundin SB; Hansson LE; Sjövall H; Svennerholm AM
    Helicobacter; 2013 Feb; 18(1):73-82. PubMed ID: 23067268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
    Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
    APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LTA 252GG and GA genotypes are associated with diffuse-type noncardia gastric cancer risk in the Japanese population.
    Suzuki G; Cullings H; Fujiwara S; Matsuura S; Kishi T; Ohishi W; Akahoshi M; Hayashi T; Tahara E
    Helicobacter; 2009 Dec; 14(6):571-9. PubMed ID: 19889075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori and stomach cancer: a case-control study in Venezuela.
    Plummer M; Vivas J; Fauchère JL; Del Giudice G; Peña AS; Ponzetto A; Lopez G; Miki K; Oliver W; Muñoz N
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):961-5. PubMed ID: 11008915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori infection and gastroesophageal reflux in a population-based study (The HUNT Study).
    Nordenstedt H; Nilsson M; Johnsen R; Lagergren J; Hveem K
    Helicobacter; 2007 Feb; 12(1):16-22. PubMed ID: 17241296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Negative Anti-
    Inoue M; Sawada N; Goto A; Shimazu T; Yamaji T; Iwasaki M; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):420-426. PubMed ID: 31826914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori infection in gastric carcinoma.
    Kato T; Saito Y; Niwa M; Inoue H; Motoyama N; Ogoshi K; Nashimoto A; Sasaki J; Sato T; Asaka M
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S93-6. PubMed ID: 7735944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk for gastric cancer after antibiotic prophylaxis in patients undergoing hip replacement.
    Akre K; Signorello LB; Engstrand L; Bergström R; Larsson S; Eriksson BI; Nyrén O
    Cancer Res; 2000 Nov; 60(22):6376-80. PubMed ID: 11103800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan.
    Lin JT; Wang LY; Wang JT; Wang TH; Yang CS; Chen CJ
    Anticancer Res; 1995; 15(2):603-6. PubMed ID: 7763044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
    Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.